QNTM Stock Analysis: Buy, Sell, or Hold?
QNTM - Quantum Biopharma Ltd. Class B Subordinate Voting Shares
$3.85
0.19 (5.19%)
▲
5d:
+4.05%
30d:
-50.7%
90d:
+24.19%
BUY
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Get Alerted When QNTM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: QNTM shows positive signals but monitor for confirmation. Moderate conviction.
💡 BUY OPPORTUNITY: QNTM shows positive signals but monitor for confirmation. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: QNTM is currently trading at $3.85, which is considered slightly low relative to its 30-day fair value range of $3.63 to $7.01.
Technical Outlook: Technically, QNTM is in a uptrend. Immediate support is located at $3.59, while resistance sits at $7.83. The stock is showing strong short-term momentum, up 5.2% recently.
Market Sentiment: QNTM has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $12.30 (+219.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, QNTM is in a uptrend. Immediate support is located at $3.59, while resistance sits at $7.83. The stock is showing strong short-term momentum, up 5.2% recently.
Market Sentiment: QNTM has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $12.30 (+219.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$3.63 -
$7.01
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.2%)
- BULLISH: Trading 219.5% below Wall St target ($12.30)
Trading Range Analysis
30-Day Trading Range
$3.63 -
$7.01
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$3.59
Resistance Level
$7.83
Current Trend
Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Wall Street Target
$12.30
(+219.5%)
Share & Embed Analysis
Last updated: June 24, 2026 6:55 AM ET
Data refreshes hourly during market hours. Next update: 7:55 AM
Data refreshes hourly during market hours. Next update: 7:55 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is QNTM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 56 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 57 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1022 | 67 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |